FCRL5-Directed CAR T-Cell Therapy: A Novel Therapeutic Approach for Multiple Myeloma

by | May 8, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

CAR T-cells specifically targeting FCRL5, when integrated with IL-15, may improve cytotoxicity, thereby enhancing the therapeutic potency of these cells.
Read More

Submit a Comment